Quarterly report pursuant to Section 13 or 15(d)

Stockholders' Equity (Tables)

v3.20.1
Stockholders' Equity (Tables)
3 Months Ended
Mar. 31, 2020
Stockholders' Equity Note [Abstract]  
Schedule of stock-based compensation
    For the Three Months Ended March 31,  
    2020     2019  
Research and development   $ 212,429     $ 272,811  
General and administrative     670,216       490,848  
Total   $ 882,645     $ 763,659  
Schedule of stock option activity

                Weighted Average        
    Stock Options     Exercise Price     Fair Value     Contractual     Aggregate
Intrinsic
 
    Outstanding     Exercisable     Outstanding     Exercisable     Vested     Life (Years)     Value  
Balance – December 31, 2019     7,632,358       4,542,144     $ 2.21     $ 1.57     $ 1.57       6.44     $ -  
Granted     125,000       -       -       -       -       -       -  
Exercised     (71,981 )     -       -       -       -       -       -  
Cancelled     -       -       -       -       -       -       -  
Balance – March 31, 2020     7,685,377       4,616,153     $ 2.23     $ 1.63     $ 1.63       6.44     $ 1,227,795  

Schedule of stock options outstanding and exercisable

      Weighted Average                 Weighted Average
Grant Price     Exercise     Total     Number     Remaining
From     To     Price     Outstanding     Exercisable     Contractual Term
$ 0.26     $ 2.02     $ 0.90       3,218,376       3,029,209      4.06 years
$ 2.10     $ 4.60     $ 2.46       3,774,001       1,097,791      8.44 years
$ 5.30     $ 8.86     $ 6.62     693,000     489,153      8.11 years
                   Totals         7,685,377     4,616,153      

Schedule of warrants activity

                Weighted Average        
    Warrants     Exercise Price     Fair Value     Contractual     Aggregate
Intrinsic
 
    Outstanding     Exercisable     Outstanding     Exercisable     Vested     Life (Years)     Value  
Balance – December 31, 2019     4,907,223       4,907,223     $ 2.40     $ 2.40     $ 1.11       1.55     $ -  
Granted     -       -       -       -       -       -       -  
Exercised     -       -       -       -       -       -       -  
Cancelled     -       -       -       -       -       -       -  
Balance – March 31, 2020     4,907,223       4,907,223     $ 2.40     $ 2.40     $ 1.11       2.02     $ 703,765